Tag: Transgender
Gender-Affirming Hormone Therapy Tied to Systolic BP Changes
Within two to four months, increases, decreases in systolic BP seen in transmasculine, transfeminine adults, respectively
42 Percent of Transgender Women With Valid HIV Test Are HIV+
Prevalence varies by race/ethnicity, ranging from 17 percent among Whites to 65 percent among American Indian/Alaska Natives
Erythrocytosis ID’d in 11 Percent of Trans Men Using Testosterone
Factors associated with erythrocytosis include tobacco use, long-acting undecanoate injections, age at initiation of testosterone
Estrogen Therapy Need Not Stop for Gender-Affirming Surgery
Authors find that perioperative venous thromboembolism rarely occurs, regardless of suspension of hormone therapy prior to surgery
Obesity, Eating Disorders More Common in Sexual-, Gender-Minority Youth
Findings suggest that disparities in weight, eating disorders observed in SGM adolescents/adults may emerge in childhood
Lack of Insurance Tied to Non-Rx Hormone Use in Transgender Adults
Authors say insurance barrier poses risks to safety, health, and well-being
AHA: CVD Risk Often Unaddressed for Transgender Population
Of those receiving gender-affirming hormone therapy, many have CV risk factors and are not receiving appropriate therapies
Timing of Gender-Affirming Care Linked to Mental Health
Gender-Concordant ID May Aid Mental Health in Trans Adults
